The relatively high ORR in patients with primary uterine PEComas is consistent with that of the overall study population and contrasts with retrospective reports of lower sensitivity of uterine PEComas to mTOR inhibitors.4 This evidence concerns the gene MTOR and neoplasm with perivascular epithelioid cell differentiation.